Prescription drug · ANDA
mupirocin NDC 45802-112
Mupirocin 20 mg/g · Ointment · Topical · Padagis Israel Pharmaceuticals Ltd
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 45802-112-14 | 45802011214 | 1 TUBE in 1 CARTON (45802-112-14) / 15 g in 1 TUBEMarketed from Oct 8, 2022 | |
| 45802-112-22 | 45802011222 | 1 TUBE in 1 CARTON (45802-112-22) / 22 g in 1 TUBEMarketed from Oct 30, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- mupirocin
- Generic name (nonproprietary)
- mupirocin
- Active ingredients
- Mupirocin — 20 mg/g
- Dosage form
- Ointment
- Route
- Topical
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065123
- Marketing start
- Listing expires
- Other FDA classes
- RNA Synthetase Inhibitors (Mechanism)
- Identifiers
- Product ID 45802-112_d51e7348-2495-41d4-93c1-bfaef2dac375SPL ID d51e7348-2495-41d4-93c1-bfaef2dac375SPL set ID e9b61f01-3c67-42a4-a62b-10f1d1343190RxCUI 106346UNII D0GX863OA5
- Pharmacologic class
- RNA Synthetase Inhibitor Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N445802011214followed by a unit qualifier and the quantityPackage 45802-0112-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes) . Mupirocin Ointment USP, 2% is an RNA synthetase inhibitor antibacterial indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 065123
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | Proficient Rx LP | 63187-261 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | Bryant Ranch Prepack | 72162-2270 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | NuCare Pharmaceuticals,Inc. | 68071-4789 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | Preferred Pharmaceuticals Inc. | 68788-8642 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | Bryant Ranch Prepack | 63629-8687 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | ATLANTIC BIOLOGICALS CORP. | 17856-0112 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | St. Mary's Medical Park Pharmacy | 60760-960 |
| Mupirocinmupirocin ointment | Mupirocin 20 mg/g | OintmentTopical | Kesin Pharma Corporation | 81033-032 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | Asclemed USA, Inc. | 76420-128 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | HAWAII REPACK, INC. | 85534-0038 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | A-S Medication Solutions | 50090-1587 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | Bryant Ranch Prepack | 71335-2829 |
| mupirocin | Mupirocin 20 mg/g | OintmentTopical | REMEDYREPACK INC. | 70518-1808 |